GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (OTCPK:MDBIF) » Definitions » YoY EPS Growth

MDBIF (TrivarX) YoY EPS Growth : 100.00% (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is TrivarX YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. TrivarX's YoY EPS Growth for the quarter that ended in Dec. 2024 was 100.00%.

TrivarX's Earnings per Share (Diluted) for the six months ended in Dec. 2024 was $0.00.


TrivarX YoY EPS Growth Historical Data

The historical data trend for TrivarX's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TrivarX YoY EPS Growth Chart

TrivarX Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 84.94 75.41 -480.00 86.21 83.33

TrivarX Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.33 86.59 -100.00 100.00 100.00

TrivarX YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

TrivarX's YoY EPS Growth for the fiscal year that ended in Jun. 2024 is calculated as:

YoY EPS Growth (A: Jun. 2024 )
=(Earnings per Share (Diluted) (A: Jun. 2024 )-Earnings per Share (Diluted) (A: Jun. 2023 ))/ | Earnings per Share (Diluted) (A: Jun. 2023 ) |
=(-0.002--0.012)/ | -0.012 |
=83.33 %

TrivarX's YoY EPS Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EPS Growth (Q: Dec. 2024 )
=(Earnings per Share (Diluted) (Q: Dec. 2024 )-Earnings per Share (Diluted) (Q: Dec. 2023 )) / | Earnings per Share (Diluted) (Q: Dec. 2023 )) |
=(-0--0.002)/ | -0.002 |
=100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TrivarX YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of TrivarX's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


TrivarX Business Description

Traded in Other Exchanges
Address
647 Beaufort Street, Mount Lawley, WA, AUS, 6050
TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx's clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability.

TrivarX Headlines

From GuruFocus

Medibio Releases Corporate Health Product, ilumen™

By Marketwired Marketwired 10-03-2018

Receipt of $3,146,835 R&D Tax Incentive Refund

By Marketwired Marketwired 10-15-2018

Medibio Limited Quarterly ASX Update and Cashflows

By Marketwired Marketwired 10-30-2018

Medibio Named Finalist for Prestigious Optus My Business Award

By Marketwired Marketwired 10-01-2018

Departure of Managing Director & Chief Executive Officer

By Marketwired Marketwired 08-29-2018

Medibio Announces Executive Leadership Changes

By Marketwired Marketwired 09-21-2018

Medibio Market Update

By Marketwired Marketwired 11-02-2018